The impact of polymorphisms in the IL23R gene on the response to anti-TNF drugs in biologic-naive patients diagnosed with moderate-to-severe psoriasis has been evaluated in a study with Spanish patients (n = 109). This evidence concerns the gene IL23R and psoriasis.